Across the SURPASS trials documented in the Mounjaro FDA prescribing information, injection-site reactions occurred in approximately 3-7% of participants depending on dose, while true systemic allergic responses (hives spreading beyond the site, facial swelling, breathing difficulty) are rare
doi: 10.1056/NEJMoa2306963 29 SkrobuchaAPindlowskiPKrajewskaNGrabowskiMJonikS
TABLE 2 Botanical drug authentication (ConPhyMP Table 1)
Conversely, real-world patients may receive more routine monitoring and earlier intervention, potentially catching and preventing clots before they become clinically significant events
The other senior author is Markus Stoffel, MD, PhD, professor of metabolic diseases at the Institute of Molecular Health Sciences, ETH Zurich in Switzerland
The organization represents professionals who lead the business offices of roughly 15,000 medical practices